← back to search

Jean-Pierre Ayoub

Centre Hospitalier de l’Université de Montréal · CA
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Treatment and Pharmacology, PARP inhibition in cancer therapy, Advanced Breast Cancer Therapies, and Colorectal Cancer Treatments and Studies.
h-index
17
citations
2,836
works
54
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trial
European Journal of Cancer 2024cited by 17position: middledoi
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology 2020cited by 319position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christine K. Ratajczak · AbbVie (United States)2 papers (2020–2024)Banu Arun · The University of Texas MD Anderson Cancer Center2 papers (2020–2024)Michael Friedländer · University of South Wales2 papers (2020–2024)Hans Wildiers · CHU Dinant Godinne UCL Namur2 papers (2020–2024)Véronique Dièras · Centre Eugène Marquis2 papers (2020–2024)Hyo S. Han · Moffitt Cancer Center2 papers (2020–2024)Shannon L. Puhalla · UPMC Hillman Cancer Center2 papers (2020–2024)Matthew W. Dudley · AbbVie (United States)1 papers (2020–2020)Cristina Oprean · Polytechnic University of Timişoara1 papers (2020–2020)Markéta Palácová · Masaryk Memorial Cancer Institute1 papers (2020–2020)Vincent Girardi · Amgen (United States)1 papers (2024–2024)Nikhil Khandelwal · AbbVie (United States)1 papers (2020–2020)Igor Bondarenko · Dnipro State Medical University1 papers (2020–2020)Hephzibah Adamu · AbbVie (United States)1 papers (2024–2024)Eduardo Yáñez · Universidad de La Frontera1 papers (2020–2020)Mathilde Jalving · University Medical Center Groningen1 papers (2020–2020)Madan G. Kundu · Daiichi Sankyo (United States)1 papers (2020–2020)Bella Kaufman · NYU Langone Health1 papers (2020–2020)David Maag · Intellia Therapeutics (United States)1 papers (2020–2020)Erik Jakobsen · Region of Southern Denmark1 papers (2020–2020)